193 related articles for article (PubMed ID: 2580255)
1. High-risk metastatic gestational trophoblastic disease.
Gordon AN; Gershenson DM; Copeland LJ; Saul PB; Kavanagh JJ; Edwards CL
Obstet Gynecol; 1985 Apr; 65(4):550-6. PubMed ID: 2580255
[TBL] [Abstract][Full Text] [Related]
2. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
Lurain JR; Brewer JI
Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
[TBL] [Abstract][Full Text] [Related]
3. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
4. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
Soper JT; Clarke-Pearson D; Hammond CB
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
[TBL] [Abstract][Full Text] [Related]
5. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
6. [Gestational trophoblastic tumors--a report of experiences].
Ebeling K; Schönborn I; Johannsmeyer D
Zentralbl Gynakol; 1995; 117(5):237-42. PubMed ID: 7540787
[TBL] [Abstract][Full Text] [Related]
7. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
Mortakis AE; Braga CA
Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
[TBL] [Abstract][Full Text] [Related]
8. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
9. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
[TBL] [Abstract][Full Text] [Related]
11. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
12. High-risk metastatic gestational trophoblastic tumors. Current management.
Lurain JR
J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
[TBL] [Abstract][Full Text] [Related]
13. [Methotrexate in gynecologic oncology].
Isonishi S; Terashima Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
[TBL] [Abstract][Full Text] [Related]
14. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
15. High-dose methotrexate for gestational trophoblastic disease.
Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
[TBL] [Abstract][Full Text] [Related]
16. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
17. Brain metastases of gestational trophoblastic tumor.
Bakri Y; Berkowitz RS; Goldstein DP; Subhi J; Senoussi M; von Sinner W; Jabbar FA
J Reprod Med; 1994 Mar; 39(3):179-84. PubMed ID: 7518516
[TBL] [Abstract][Full Text] [Related]
18. Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
Newlands ES; Holden L; Seckl MJ; McNeish I; Strickland S; Rustin GJ
J Reprod Med; 2002 Jun; 47(6):465-71. PubMed ID: 12092015
[TBL] [Abstract][Full Text] [Related]
19. 5-day methotrexate for women with metastatic gestational trophoblastic disease.
Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Gynecol Oncol; 1994 Jul; 54(1):76-9. PubMed ID: 8020843
[TBL] [Abstract][Full Text] [Related]
20. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease.
Khoo SK; Jones IS
Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
